Skip to content

The effect of intraperitoneal spraying of ropivacaine on postoperative visceral pain during laparoscopic cholecystectomy: a prospective, double-blind, randomized controlled clinical study

The effect of intraperitoneal spraying of ropivacaine on postoperative visceral pain during laparoscopic cholecystectomy: a prospective, double-blind, randomized controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081925
Enrollment
Unknown
Registered
2024-03-15
Start date
2024-03-18
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallstone

Interventions

The patient is given preoperative oral NSAIDS drugs+intraoperative local spraying of ropivacaine on the abdominal wound+incision injection of ropivacaine:The patient is given preoperative oral NSAIDS
The patient is given preoperative oral NSAIDS drugs and incision ropivacaine injection:The patient is given preoperative oral NSAIDS drugs and incision ropivacaine injection

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with gallstones, with or without chronic cholecystitis, with indications for LC surgery, and planning to undergo LC surgery; 2) Stones can be single or multiple; 3) 18 years old = Age = 65 years old; 4) 18kg/m2 = BMI = 30 kg/m2; 5) Not participating in other clinical trials; 6) No previous history of diabetes; 7) No previous history of abdominal surgery; 8) ASA Level 1-2; 9) Clear mind, clear thinking, no mental illness, able to understand and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1) Combined (or suspected) presence of common bile duct stones; 2) Concomitant (or suspected) gallbladder cancer; 3) ASA surgical grade = Level III; 4) Other organ dysfunction; 5) Concomitant liver lesions require liver resection; 6) Pregnant women; 7) Previous history of upper abdominal surgery; 8) Highly suspected intra-abdominal adhesions before surgery; 9) Patients diagnosed with scar constitution; 10) Chronic disease patients who require long-term oral hormone therapy; 11) Individuals who abuse alcohol or drugs within a year will be tested using the Alcohol Use Disorders Identification Test (AUDIT).

Design outcomes

Primary

MeasureTime frame
VRS;VAS;

Countries

China

Contacts

Public ContactYanWen Jin

Biliary Surgery Department of West China Hospital of Sichuan University

2935443376@qq.com+86 157 0829 1844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026